Argenx Se (ARGX) SEC Filing 6-K Foreign Issuer report for the period ending Monday, October 1, 2018

Argenx Se

CIK: 1697862 Ticker: ARGX

View differences made from one to another to evaluate Argenx Se's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Argenx Se.


Assess how Argenx Se's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Argenx Se's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Argenx Se provided additional information to their SEC Filing as exhibits

Ticker: ARGX
CIK: 1697862
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-18-063755
Submitted to the SEC: Thu Oct 25 2018 6:03:08 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Monday, October 1, 2018
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: